HOME
SEARCH
RSS FEED
SUBSCRIBE
Constituents of Morning Glory as Anticancer Agents
Case ID:
05.036
Web Published:
9/3/2012
Ipomoeassin compounds derived from morning glory plant material (especially
Ipomoea
sp. from Suriname) are useful as anti-cancer agents. The novel compounds also are useful for treating neurodegenerative disorders (such as Alzheimer's disease) in human patients.
Patent Information:
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Patent Status
US Utility
*United States
11/366,806
7,560,536
3/3/2006
7/14/2009
Abandoned
Category(s):
Biomedical
Bookmark this page
Download as PDF
For Information, Contact:
Mike Miller
Senior Licensing Manager
Virginia Tech Intellectual Properties, Inc.
(540) 443-9228
mmiller@vtip.org
Inventors:
David Kingston
Shugeng Cao
Keywords: